[1] Eriksson P,Deguchi H,Samnegrd A,et al.Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease[J].Arterioscler Thromb Vasc Biol,2004,24(3):551-557.
[2] 陈小奇,徐沙贝,王伟,等.血浆半胱氨酸蛋白酶抑制剂C水平与脑梗死关系[J].神经损伤与功能重建,2009,4(2):88-89.
[3] Bengtsson E,To F,Grubb A,et al.Absence of the protease inhibitor cyctation C in inflammatory cells results in larger plaque area in plaque regression of apoE-deciemtmice[J].Atherosclerosclerosis,2005,180(1):45-53.
[4] Koening W,Twardella D,Brennern H,et al.Plasma concentrations of cyctation C in patients with coronary heart disease and risk for secondary cardiovascular events;more than Jimply a marker of glomerular flitration rate[J].Clin Chem,2005,51(2):321-327.
[5] 林红霞,樊锦秀,陈琦.不同年龄段脑梗死患者胱氨酸酶抑制剂C变化及临床意义[J].现代实用医学,2008,7(4):682-685.
[6] 李京华,李江,曹宁,等.急性脑梗死患者同型半胱氨酸及胱氨酸蛋白酶抑制剂C水平变化及意义[J].中国神经免疫学及神经病学,2008,7(2):282-284.
[7] 方军,洪灵敏.急性脑梗死患者血清胆红素和胱抑素C水平变化及意义[J].中国实验诊断学,2007,11(6):835-836.
[8] 冯骏,秦皓,刘丽华,等.老年急性脑梗死患者颈动脉斑块与血清C反应蛋白、脂蛋白(a)和血糖水平的关系[J].中国老年学杂志,2011,31(9):1536-1538.